Pranlukast (n=10) | Placebo (n=7) | Estimated median difference (95% CI) | |||||||
---|---|---|---|---|---|---|---|---|---|
Before | After | Median difference | Before | After | Median difference | ||||
CD3 | 88.5 | 64 | 28.53-150 | 110 | 125 | −10 | −37 (−69 to −1)3-150 | ||
CD4 | 59 | 35.5 | 243-150 | 70 | 80 | −5 | −28 (−49 to −8)** | ||
CD8 | 42.5 | 34 | 10 | 40 | 45 | −5 | −16 (−56 to 15) | ||
CD68 | 62.5 | 55.5 | 16.5 | 110 | 120 | 8 | −13 (−33 to 24) | ||
NP57 | 16.5 | 16 | 3 | 17 | 18 | 0 | 0 (−9 to 17) | ||
AA1 | 26.5 | 12.5 | 11.53-150 | 47 | 50 | −3 | −15 (−26 to 0)3-150 | ||
EG1 | 34.5 | 18 | 10.5 | 34 | 30 | 5 | −9 (−35 to 20) | ||
EG2 | 25.5 | 7 | 20.5** | 35 | 35 | −3 | −18 (−35 to 0)3-150 | ||
γGTP | 41.5 | 34 | 11 | 32 | 41 | 2 | −5 (−22 to 22) | ||
CD19 | 7 | 6 | 1.5 | 5 | 4 | 1 | −1 (−7 to 2) |
↵3-150 p<0.05; **p<0.01.